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Aging is a complex process strongly determined by genetics. Previous reports have shown that the genome of neuronal cells
displays somatic genomic mosaicism including DNA copy number variations (CNVs). CNVs represent a significant source of
genetic variation in the human genome and have been implicated in several disorders and complex traits, representing a
potential mechanism that contributes to neuronal diversity and the etiology of several neurological diseases and provides
new insights into the normal, complex functions of the brain. Nonetheless, the features of somatic CNV mosaicism in
nondiseased elderly brains have not been investigated. In the present study, we demonstrate a highly significant increase in
the number of CNVs in nondiseased elderly brains compared to the blood. In two neural tissues isolated from paired
postmortem samples (same individuals), we found a significant increase in the frequency of deletions in both brain areas,
namely, the frontal cortex and cerebellum. Also, deletions were found to be significantly larger when present only in the
cerebellum. The sizes of the variants described here were in the 150–760 kb range, and importantly, nearly all of them
were present in the Database of Genomic Variants (common variants). Nearly all evidence of genome structural variation
in human brains comes from studies detecting changes in single cells which were interpreted as derived from independent,
isolated mutational events. The observations based on array-CGH analysis indicate the existence of an extensive clonal
mosaicism of CNVs within and between the human brains revealing a different type of variation that had not been
previously characterized.
1. Introduction
Aging is a complex process that involves altered cellular func-
tion, oxidative stress, longevity, and related diseases [1]. An
important challenge for future research is to understand
how genetics influences cognition and the neurobiological
mechanisms underlying normal and pathological aging. It
is expected that genetic variants may contribute to the con-
siderable individual differences in cognitive aging by altering
brain plasticity [2, 3]. Interestingly, previous reports have
shown that individual neurons display somatic genomic
mosaicism [4]. Although the effects of this somatic mosai-
cism are not fully understood, it is expected that alterations
in the genome of neuronal cells will influence both the
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normal and the diseased brains. The forms of somatic geno-
mic mosaicism identified in the human brain include aneu-
ploidy [5], mobile genetic element insertions (MEIs) [6, 7],
single-nucleotide variants (SNVs), indels [8], and, more
recently, DNA copy number variations (CNVs) [4, 9].
CNVs represent a prevalent form of genetic variation that
contributes to phenotypic diversity, numerous diseases, and
complex traits in human populations [10]. The mechanisms
by which copy number changes may affect gene expression,
and phenotypic traits comprise alteration of gene dosage
and disruption of coding sequences or regulatory elements
[10]. McConnell and colleagues were the first to demonstrate
increased levels of CNVs in cortical neurons derived from
postmortem specimens and human-induced pluripotent stem
cell (hiPSC) fibroblast-derived neurons compared to blood
samples using a single-cell sequencing strategy [11]. The
authors identified in both samples a subset of aneuploid neu-
rons as well as numerous subchromosomal CNVs. Because of
the long lifespan of neurons and their central role in synap-
ses, it is speculated that the accumulation of somatic muta-
tions within neural progenitor cells or in postmitotic
neurons could influence neuronal development, complexity,
and function. In this regard, genomic mosaicism in single,
sporadic Alzheimer’s disease neurons characterized by an
increase in total DNA content and amyloid precursor protein
(APP) gene copy number was reported [12]. The authors also
showed large differences in the total DNA content between
different brain areas, which may indicate distinct functional-
ity for genomic mosaicism in the central nervous system.
The existence of region-specific somatic mosaicism of
DNA content was also demonstrated in nondiseased human
brains, suggesting that sporadic brain diseases may depend
on which pathogenic loci are altered [12, 13]. However, the
features of mosaic CNV in nondiseased elderly brains have
not been characterized. It is not clear yet when and what pro-
motes CNV formation in human brains or how does it relate
to aging. Moreover, it is worth to mention that nearly all evi-
dence of genome structural variation in human brains comes
from studies detecting changes in single cells, either by FISH
for detection of chromosomal aneuploidy or by total DNA
sequencing of single cells for chromosomal structural rear-
rangements. The genomic changes observed in single cells
were interpreted as derived from independent, isolated muta-
tional events. In this study, based on a comparative array-
comparative genomic hybridization (array-CGH) analysis
of two brain tissues and blood-isolated postmortem samples
from the same individuals, we report the existence of an
extensive clonal mosaicism for CNV in and between the cer-
ebellum and the frontal cortex compared to the blood, which
probably reflects a higher mutation rate in neural tissues.
2. Materials and Methods
2.1. Postmortem DNA Samples. All the samples used in this
study were provided by the Brain Bank of the Brazilian Aging
Brain Study Group (BBBABSG) [14, 15]. The clinical and
functional status of all subjects was assessed through the closest
family member to the deceased who completed questionnaires
on whether or not the subject was demented or suffered from
other possible neural conditions, including a previous history
of stroke, epilepsy, or Parkinson’s disease. All questionnaires
were based on a validated clinical protocol that includes a
series of semistructured scales covering major functional abili-
ties [16, 17] and cognitive evaluation by the Clinical Dementia
Rating Scale [18] and the Informant Questionnaire on Cog-
nitive Decline in the Elderly [19]. As a standard protocol for
neuropathological diagnosis, the brain was examined macro-
scopically, and 15 brain regions were sampled for microscopic
evaluation. Neuropathological examinations were carried out
using immunohistochemistry following internationally
accepted guidelines [20–23]. BBBABSG’s procedures are
approved by the Ethical Board of the University of São Paulo
Medical School, and the next of kin agreed to participate and
signed an informed written consent. Initially, investigations
on CNV frequencies were derived from array-CGH data taken
from 24 blood and 71 cerebellum independent samples (differ-
ent individuals). Subsequently, 19 paired blood/cerebellum
samples from the same individuals were used to confirm the
differences in CNV frequencies between the two tissues. In
addition to the paired samples from 19 individuals, we
obtainedmatched frontal cortex tissues from 10 of the individ-
uals. Table 1 presents the characterization of all individuals
classified from the paired analysis cohort.
2.2. Array-CGH. CNVs were identified using comparative
genomic hybridization based on microarrays (array-CGH)
containing 180,000 oligonucleotides (Oxford Gene Tech-
nologies, UK). Briefly, samples were labeled with Cy3-
and Cy5-deoxycytidine triphosphates by random priming.
Purification, hybridization, and washing were carried out as
previously reported [24]. Scanned images of the arrays were
processed using Feature Extraction software, and data were
analyzed with the Genomic Workbench software, both soft-
ware from Agilent Technologies (Santa Clara, CA, USA).
CNVs were identified using the aberration detection method
2 statistical algorithm (ADM2) with a sensitivity threshold of
6.7. A genomic segment was considered duplicated or deleted
when the log2 ratio of the test/reference fluorescent intensi-
ties of a given region encompassing at least three probes
which were above 0.3 or below −0.3, respectively. The equiv-
alency between the log2 ratios of the test/reference for dupli-
cations is 0.58 and for deletions is −1. Detected CNVs were
compared to CNV data from oligoarray studies documented
in the Database of Genomic Variants (DGV).
2.3. Statistical Analyses. Data are presented as the mean
± SEM. Statistical analyses (GraphPad Prism 6.0 software,
San Diego, CA, USA) were performed using the nonparamet-
ric Mann–Whitney U test for the comparison between two
groups. One-way ANOVA followed by Bonferroni’s post hoc
test was applied to estimate themean differences between three
groups. Two-way ANOVA was used to compare the mean dif-
ferences between groups with two independent variables.
3. Results
The investigation of CNVs by array-CGH in independent
samples of nondemented elderly individuals revealed a highly
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significant increase in the frequency of CNVs in postmortem
samples from the cerebellum (n = 71) compared to blood
samples (n = 24) (Mann–Whitney U test, p < 0 0001)
(Figure 1(a)). This finding was later confirmed in 19 paired
blood/cerebellum samples taken from the same individuals
(Mann–Whitney U test, p < 0 001) (Figure 1(b)). Figure 1(c)
shows an example of many more copies of a segment of
chromosome 8 in the cerebellum than in the blood. For some
of the paired cerebellum/blood samples, we were also able to
obtain matched frontal cortex tissue and determine the
distribution of CNVs between these two neural tissues within
the same individuals.
The distribution of absolute CNV numbers in the
frontal cortex and cerebellum revealed high heterogeneity
both between individuals and tissues (two-way ANOVA,
p < 0 001) (Figure 2(a)). Further inspection using a Venn
diagram (Figure 2(b)) shows the proportion of CNVs
observed exclusively either in the frontal cortex or in the
cerebellum (referred to as unique CNVs). In total, 75% of
the CNVs correspond to unique mutations to one of these
two neural tissues (43% in the frontal cortex and 32% in the
cerebellum). The remaining 25% refers to CNVs in common
to both tissues, suggesting that they were acquired earlier
during brain development. All the 159 CNVs identified in
these two brain areas are presented in Supplementary
Table 1. We also evaluated the CNVs regarding the
frequency of deletions and duplications, their length, and
gene content. For both in common and in unique CNVs
from the frontal cortex and cerebellum, the frequency of
deletions was higher than that of duplications (two-way
ANOVA, p < 0 05, Figure 2(c)). Comparing the lengths of
the CNVs, the mean sizes of duplications and deletions
differed significantly among groups (∗p < 0 05, one-way
ANOVA), and the unique deletions from the cerebellum
were significantly larger than the ones in common
(Bonferroni’s test, p < 0 05). Nonetheless, in the present
data, neither the length nor gene content of the unique
CNVs from the frontal cortex and cerebellum areas were
significantly different from each other (Table 2).
Importantly, nearly all the observed CNVs in this study,
either present in both brain tissues or exclusively to one of
them, had already been described in the Database of Genomic
Variants (DGV) as polymorphic, beingmost of them segmen-
tal duplications (Figure 2(d)). Figure 3 shows two examples of
somatic duplications that are present in the frontal cortex but
absent in the cerebellum. As in most of the CNVs observed in
this study, the amplified segment involves a gene family with
variable copy number variation in the population.
Using the ingenuity pathway analysis (IPA) software
(QIAGEN Inc., https://www.qiagenbioinformatics.com/
products/ingenuitypathway-analysis), we retrieved the
predicted target pathways of all the CNVs identified in the
frontal cortex and cerebellum and found enrichment for
antigen presentation and regulation cytokine production
pathways, respectively (Figure 4); the top diseases/function
of all networks retrieved from both neural tissues are
presented in Supplementary Table 2.
4. Discussion
Several studies have demonstrated that neuronal genomes
exhibit somatic genomicmosaicism compared to other tissues
including CNVs [4]. Notably, genome structural variation in
the human brain has been reported in single cell studies, using
either FISH orDNA sequencing involving large-scale changes
such as aneuploidy and structural rearrangements of more
Table 1: Clinical data of all individuals classified as nondemented included in the paired analysis cohort.
Case Sex Age at death Schooling (years of formal education) Neuropathological diagnosis Cause of death
1 M 83 14 Normal Ischemic cardiomyopathy
2 F 97 4 Normal Dilated cardiomyopathy
3 F 73 12 Normal Acute infarction myocardial
4 F 77 3 Normal Tromboembolism pulmonar
5 M 64 4 Normal Acute infarction myocardial
6 F 66 4 Normal Healed myocardial infarction
7 F 67 4 Normal Bilateral bronchopneumonia
8 F 62 1 Normal Hemopericardium
9 F 70 4 Normal Myocarditis
10 M 63 11 Normal Acute infarction myocardial
11 F 81 11 Normal Pulmonary edema
12 F 77 2 Normal Hemopericardium
13 M 81 13 Normal Bronchopneumonia
14 F 65 11 Normal Acute infarction myocardial
15 M 76 4 Normal Acute lung edema/myocardiopathy
16 F 75 4 Normal Acute lung edema
17 M 50 13 Normal Hypertensive cardiopathy
18 F 89 8 Normal Acute infarction myocardial
19 M 85 2 Normal Pulmonary edema
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than 7Mb [11, 25]. Our study is the first to investigate the
clonal CNV burden within different neural tissues in nondi-
seased elderly brains using direct microarray analysis.
In contrast to previous studies on single cells using either
FISH or DNA sequencing, our results, based on array-CGH
analysis, represent genomic changes in DNA pools from a
large number of cells from each tissue investigated, which
indicates that at least some of these increase in CNV variation
in human brains relative to the blood must occur as extensive
clones rather than isolated events. The presence of extensive
clones involving different CNVs indicates that these CNVs
must either have been present in the germline (constitutive)
or have originated early in embryonic development and could
be distinguished from partial chromosome aneuploidies or
large copy number variations as detected by FISH and/or
sequencing of single cells [11, 26, 27]. The frequency of unique
CNVs in each tissue is probably proportional to the CNV
mutation rate for each tissue and should reflect CNV
mutation rate differences between tissues. Significantly, nearly
all the observed CNVs, both CNVs in common to both neural
tissues and presumptively new mutations, had already been
described in the Database of Genomic Variants (DGV) as
polymorphic, and the amplified segment involves a gene
family with variable copy number variation in the population,
being most of them segmental duplications. This evidence
suggests that many of these variants arose commonly and
perhaps involve similar mechanisms in their origin, the
nonallelic homologous recombination [10].
The CNV distribution within different human brain
areas was highly heterogeneous both between individuals
and tissues. A previous study based on flow cytometry
demonstrated that the frontal cortex exhibits more variation
in DNA content than the cerebellum [13] Although we did
not quantify variation in DNA content across our DNA
samples from the frontal cortex and cerebellum, we exam-
ined whether such differences in DNA content described by
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Figure 1: Increase frequency of DNA copy number variation (CNVs) in neural tissue compared to the blood. (a) The mean of the total CNVs
detected in independent blood (n = 24) and cerebellum tissue (n = 71) samples; ∗∗∗p < 0 0001, Mann–Whitney U test. (b) The mean of the
total CNVs detected in paired blood and cerebellum samples from 19 random individuals; ∗∗p < 0 001, Mann–Whitney U test. (c)
Example of a CNV absent in the blood and observed in the cerebellum. Images extracted from Genomic Workbench software.
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Westra et al. might be caused by increased rates of deletion
and/or duplication in the frontal cortex compared to the
cerebellum. Albeit not statistically significant, we observed
an increase in the frequency only of duplications in the fron-
tal cortex compared to the cerebellum. However, neither the
length nor gene content of the unique CNVs from either
these two neural tissues were significantly different from each
other. Although Westra et al. reported that the variation in
DNA content averaged ~250Mb more DNA in the frontal
cortex compared to the cerebellum by flow cytometry, this
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Figure 2: Distribution of DNA copy number variations (CNVs) between two neural tissues from the same individuals. (a) Comparison of the
absolute number of CNVs detected in the frontal cortex and cerebellum from 10 paired individuals; ∗∗p < 0 001 for comparison between
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Table 2: Comparison of length and gene content of the in common and unique CNVs from the frontal cortex and cerebellum.
Copy number variation CNVs in common to both tissues Unique CNVs (frontal cortex) Unique CNVs (cerebellum)
Mean size of CNVs (kb) 319± 85/n = 40 295± 60/n = 68 436± 84/n = 51
Deletions (Kb) (p < 0 05)∗# 151± 32/n = 29 299± 88/n = 42 478± 103/n = 39
Duplications (kb) (p < 0 05)∗ 760± 261/n = 11 290± 72/n = 26 301± 125/n = 12
Gene content (kb) 1.33± 0.23/n = 40 1.57± 0.19/n = 68 1.38± 0.27/n = 51
CNVs: DNA copy number variations. (∗p < 0 05) One-way ANOVA, significant difference among means. (#p < 0 05) Bonferroni’s posttest, in common CNVs
versus unique CNVs from the cerebellum.
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difference could not be directly related to DNA copy num-
ber variation. Further, their results are possibly explicable
by a much higher involvement of retrotransposition in
the neural cortex than the cerebellum culminating in a
significantly wider variation in DNA content, similar to
the differences induced by a higher number of L1 transpo-
sitions in the human hippocampus compared to the cau-
date nucleus [6].
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IPA analysis was performed to investigate whether this
increase of CNVs in the brain could be explained by an
enrichment of pathways specific for central nervous system
function. Based on the fact that the predicted target pathways
of all brain CNVs are not specific for the central nervous sys-
tem functioning, our array-CGH analyses indicate either an
increased genomic instability or a less stringent selection
against genomic imbalances in brain tissues compared to
the blood, resulting in an increased frequency of clonal CNVs
in neural tissues. Nonetheless, the exact mechanisms leading
to such neuronal genomic instability are still a matter of spec-
ulation, but retrotransposon insertion has been demon-
strated to mediate the formation of CNVs in various brain
tissues [6] and also to involve double-strand DNA breaks
[28]. Even so, CNVs represent a significant source of genetic
variation in the human genome and have been implicated in
several disorders and complex traits, representing a potential
mechanism that contributes to neuronal diversity. Besides,
the highly significant increase of CNVs that we reported here
potentially contributes to physiologic variability and neuro-
nal plasticity and can provide new insights into the complex
functioning of the brain.
In summary, this study demonstrates an extensive
clonal mosaicism for copy number variation between two
different brain tissues. The investigation of genomic
changes based on tissue DNA instead of single cells
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revealed a different type of variation than previously
reported. The variation detected in tissue (clonal) seems
to involve smaller segments, which are variable in number
in the population, likely having a smaller phenotypic
impact than the aneuploidies or chromosome alterations
seen in single cells. Even so, they reflect a higher genomic
instability or less stringent selection in the brain than in
the blood, which deserves attention.
Data Availability
The data used to support the findings of this study are
available from the corresponding author upon request.
Conflicts of Interest
None of the authors have any conflict of interest to declare.
Acknowledgments
This work was supported by FAPESP Grants 2013/08028-1
and 2014/17132-0.
Supplementary Materials
Supplementary Table 1: all DNA copy number variations
(CNVs) identified in the frontal cortex and cerebellum. The
frequency of deletions and duplications of all unique CNVs
(observed exclusively either in the frontal cortex or in the
cerebellum) as well as the ones in common to both tissues
are presented in their respective sheets. Information about
CNV gene content, their length, and genomic position are
also presented. Supplementary Table 2: top diseases/function
of all networks retrieved from both the frontal cortex and the
cerebellum. Ingenuity pathway analysis (IPA) software
retrieved the predicted target pathways of all DNA copy
number variations (CNVs) identified exclusively in the
frontal cortex and cerebellum (unique CNVs).
(Supplementary Materials)
References
[1] A. M. Valdes, D. Glass, and T. D. Spector, “Omics technologies
and the study of human ageing,” Nature Reviews Genetics,
vol. 14, no. 9, pp. 601–607, 2013.
[2] H. Y. Zoghbi and S. T. Warren, “Neurogenetics: advancing the
“next-generation” of brain research,” Neuron, vol. 68, no. 2,
pp. 165–173, 2010.
[3] I. Reinvang, I. J. Deary, A. M. Fjell, V. M. Steen, T. Espeseth,
and R. Parasuraman, “Neurogenetic effects on cognition in
aging brains: a window of opportunity for intervention?,”
Frontiers in Aging Neuroscience, vol. 2, p. 143, 2010.
[4] M. J. McConnell, J. V. Moran, A. Abyzov et al., “Intersection of
diverse neuronal genomes and neuropsychiatric disease: The
Brain Somatic Mosaicism Network,” Science, vol. 356,
no. 6336, p. eaal1641, 2017.
[5] D. M. Bushman and J. Chun, “The genomically mosaic brain:
aneuploidy and more in neural diversity and disease,”
Seminars in Cell & Developmental Biology, vol. 24, no. 4,
pp. 357–369, 2013.
[6] J. K. Baillie, M. W. Barnett, K. R. Upton et al., “Somatic
retrotransposition alters the genetic landscape of the human
brain,” Nature, vol. 479, no. 7374, pp. 534–537, 2011.
[7] G. D. Evrony, X. Cai, E. Lee et al., “Single-neuron sequencing
analysis of L1 retrotransposition and somatic mutation in the
human brain,” Cell, vol. 151, no. 3, pp. 483–496, 2012.
[8] M. A. Lodato, M. B. Woodworth, S. Lee et al., “Somatic
mutation in single human neurons tracks developmental and
transcriptional history,” Science, vol. 350, no. 6256,
pp. 94–98, 2015.
[9] X. Cai, G. D. Evrony, H. S. Lehmann et al., “Single-cell,
genome-wide sequencing identifies clonal somatic copy-
number variation in the human brain,” Cell Reports, vol. 10,
no. 4, p. 645, 2015.
[10] L. Feuk, A. R. Carson, and S. W. Scherer, “Structural variation
in the human genome,” Nature Reviews Genetics, vol. 7, no. 2,
pp. 85–97, 2006.
[11] M. J. McConnell, M. R. Lindberg, K. J. Brennand et al., “Mosaic
copy number variation in human neurons,” Science, vol. 342,
no. 6158, pp. 632–637, 2013.
[12] D. M. Bushman, G. E. Kaeser, B. Siddoway et al., “Genomic
mosaicism with increased amyloid precursor protein (APP)
gene copy number in single neurons from sporadic Alzheimer’s
disease brains,” eLife, vol. 4, 2015.
[13] J. W. Westra, R. R. Rivera, D. M. Bushman et al., “Neuro-
nal DNA content variation (DCV) with regional and
individual differences in the human brain,” The Journal
of Comparative Neurology, vol. 518, no. 19, pp. 3981–
4000, 2010.
[14] L. T. Grinberg, R. E. de Lucena Ferretti, J. M. Farfel et al.,
“Brain bank of the Brazilian aging brain study group—a mile-
stone reached and more than 1,600 collected brains,” Cell and
Tissue Banking, vol. 8, no. 2, pp. 151–162, 2007.
[15] C. K. Suemoto, R. E. L. Ferretti-Rebustini, R. D. Rodriguez
et al., “Neuropathological diagnoses and clinical correlates in
older adults in Brazil: a cross-sectional study,” PLoS Medicine,
vol. 14, no. 3, article e1002267, 2017.
[16] S. Katz, A. B. Ford, R. W. Moskowitz, B. A. Jackson, andM.W.
Jaffe, “Studies of illness in the aged. The index of Adl: a
standardized measure of biological and psychosocial
function,” JAMA, vol. 185, no. 12, pp. 914–919, 1963.
[17] M. P. Lawton and E. M. Brody, “Assessment of older people:
self-maintaining and instrumental activities of daily living,”
Gerontologist, vol. 9, 3 Part 1, pp. 179–186, 1969.
[18] J. C. Morris, “The clinical dementia rating (CDR): current
version and scoring rules,” Neurology, vol. 43, no. 11,
pp. 2412–2414, 1993.
[19] A. F. Jorm and P. A. Jacomb, “The informant questionnaire on
cognitive decline in the elderly (IQCODE): socio-demographic
correlates, reliability, validity and some norms,” Psychological
Medicine, vol. 19, no. 04, pp. 1015–1022, 1989.
[20] H. Braak and E. Braak, “Neuropathological stageing of
Alzheimer-related changes,” Acta Neuropathologica, vol. 82,
no. 4, pp. 239–259, 1991.
[21] S. S. Mirra, A. Heyman, D. McKeel et al., “The consortium
to establish a registry for Alzheimer’s disease (CERAD).
Part II. Standardization of the neuropathologic assessment
of Alzheimer’s disease,” Neurology, vol. 41, no. 4, pp. 479–486,
1991.
[22] H. Braak, K. D. Tredici, U. Rüb, R. A. I. de Vos, E. N. H. Jansen
Steur, and E. Braak, “Staging of brain pathology related to
8 Neural Plasticity
sporadic Parkinson’s disease,” Neurobiology of Aging, vol. 24,
no. 2, pp. 197–211, 2003.
[23] I. R. A. Mackenzie, M. Neumann, E. H. Bigio et al., “Nomen-
clature and nosology for neuropathologic subtypes of fronto-
temporal lobar degeneration: an update,” Acta
Neuropathologica, vol. 119, no. 1, pp. 1–4, 2010.
[24] A. C. V. Krepischi, J. Knijnenburg, D. R. Bertola et al., “Two
distinct regions in 2q24.2-q24.3 associated with idiopathic
epilepsy,” Epilepsia, vol. 51, no. 12, pp. 2457–2460, 2010.
[25] F. Faggioli, J. Vijg, and C. Montagna, “Chromosomal
aneuploidy in the aging brain,” Mechanisms of Ageing and
Development, vol. 132, no. 8-9, pp. 429–436, 2011.
[26] S. D. Pack, R. J. Weil, A. O. Vortmeyer et al., “Individual adult
human neurons display aneuploidy: detection by fluorescence
in situ hybridization and single neuron PCR,” Cell Cycle, vol. 4,
no. 12, pp. 1758–1760, 2005.
[27] Y. B. Yurov, I. Y. Iourov, S. G. Vorsanova et al., “Aneuploidy
and confined chromosomal mosaicism in the developing
human brain,” PLoS One, vol. 2, no. 6, article e558, 2007.
[28] E. Suberbielle, P. E. Sanchez, A. V. Kravitz et al., “Physiologic
brain activity causes DNA double-strand breaks in neurons,
with exacerbation by amyloid-β,” Nature Neuroscience,
vol. 16, no. 5, pp. 613–621, 2013.
9Neural Plasticity
